Nutex Health (NUTX) Income towards Parent Company (2010 - 2026)

Nutex Health has reported Income towards Parent Company for 15 years, with the latest figure at $62.8 million in Q1 2026.

• Quarterly Income towards Parent Company rose 23.53% year-over-year to $62.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $192.3 million (up 274.84% YoY) and the FY2025 annual result came in at $180.4 million, up 29959.5% from the prior year.
• Income towards Parent Company advanced to $62.8 million in Q1 2026 per NUTX's latest filing, from $16.6 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $96.8 million in Q3 2025 and troughed at -$422.5 million in Q3 2022.
• A 5-year average of -$15.0 million and a median of -$171000.0 in 2024 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company tumbled 18348.63% in 2022, then surged 48299.5% in 2025.
• Over 5 years, Income towards Parent Company stood at -$4.4 million in 2022, then plunged by 526.86% to -$27.7 million in 2023, then jumped by 100.72% to $200000.0 in 2024, then surged by 8204.0% to $16.6 million in 2025, then jumped by 277.91% to $62.8 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered $62.8 million, $16.6 million, and $96.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.